Skip to main content

$0.062 0.002 (3.33%)

High

$0.06

Low

$0.06

Trades

18

Turnover

$32,113

Volume

526,676
30 June 2023 at 3:59pm
Register to track DXB and receive email alerts.

Clinical Study in Patients with COVID-19 Progresses

StockBot

416,823 posts

DXB released this announcement to the ASX on 25 March 2021, 9:10. The announcement is marked as price sensitive, and is 4 page(s) in length and 303.04kb in size.

You can view all announcements from DXB and see how they appear on a price chart on the announcements page.

At the date of this announcement, DXB was 0.050% short sold according to ASIC data. It was ranked the 481st most shorted stock on the ASX. It is now ranked as the 444th most shorted stock on the ASX with 0.114% of total shares short sold as of the latest reported data (26 May 2026).

Other Recent Announcements from DXB
Application for quotation of securities - DXB 29 June 2023, 9:01
Application for quotation of securities - DXB 29 June 2023, 9:00
Application for quotation of securities - DXB 29 June 2023, 8:59
Clinical Study in Patients with COVID-19 Progresses 25 March 2021, 9:10
DMX-200 Competitive Position Further Enhanced 24 March 2021, 9:28
Lapse of Unlisted Options 17 March 2021, 16:15
CLARITY 2.0 Study Progresses In Patients With COVID-19 10 March 2021, 9:25
You must login or register to post a comment.

You must be logged in to post a reply.

Register to track DXB and receive email alerts.